Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone

Pioglitazone, like other thiazolidinediones, is an insulin-sensitizing agent that activates the peroxisome proliferator-activated receptor gamma and influences the expression of multiple genes involved in carbohydrate and lipid metabolism. However, it is unknown which of these many target genes play primary roles in determining the antidiabetic and hypolipidemic effects of thiazolidinediones. To specifically investigate the role of the Cd36 fatty acid transporter gene in the insulin-sensitizing actions of thiazolidinediones, we studied the metabolic effects of pioglitazone in spontaneously hypertensive rats (SHR) that harbor a deletion mutation in Cd36 in comparison to congenic and transgenic strains of SHR that express wild-type Cd36. In congenic and transgenic SHR with wild-type Cd36, administration of pioglitazone was associated with significantly lower circulating levels of fatty acids, triglycerides, and insulin as well as lower hepatic triglyceride levels and epididymal fat pad weights than in SHR harboring mutant Cd36. Additionally, insulin-stimulated glucose oxidation in isolated soleus muscle was significantly augmented in pioglitazone-fed rats with wild-type Cd36 versus those with mutant Cd36. The Cd36 genotype had no effect on pioglitazone-induced changes in blood pressure. These findings provide direct pharmacogenetic evidence that in the SHR model, Cd36 is a key determinant of the insulin-sensitizing actions of a thiazolidinedione ligand of peroxisome proliferator-activated receptor gamma.     

EP300 contributes to high-altitude adaptation in Tibetans by regulating nitric oxide production

The genetic adaptation of Tibetans to high altitude hypoxia likely involves a group of genes in the hypoxic pathway,as suggested by earlier studies.To test the adaptive role of the previously reported candidate gene EP300 (histone acetyltransferase p300),we conducted resequencing of a 108.9 kb gene region of EP300 in 80 unrelated Tibetans.The allele-frequency and haplotype-based neutrality tests detected signals of positive Darwinian selection on EP300 in Tibetans,with a group of variants showing allelic divergence between Tibetans and lowland reference populations,including Han Chinese,Europeans,and Africans.Functional prediction suggested the involvement of multiple EP300 variants in gene expression regulation.More importantly,genetic association tests in 226 Tibetans indicated significant correlation of the adaptive EP300 variants with blood nitric oxide (NO) concentration.Collectively,we propose that EP300 harbors adaptive variants in Tibetans,which might contribute to high-altitude adaptation through regulating NO production.     

暴发脑膜脑炎流行的新型毒株的全基因序列

吉林省延边地区１９９６年６月发生无菌性脑膜脑炎流行,从病人脑脊液和粪便标本中分离到多株病毒,血清学实验证明所分离的病毒为此次无菌性脑膜脑炎流行的病因。对其中的２株病毒（Ｙａｎｂｉａｎ９６－８３ｃｓｆ和Ｙａｎｂｉａｎ９６－８５ｃｓｆ）测定了全基因核酸序列并帮了比较分析。结果所测２株病毒核酸长度均为７４５６ｂｐ〔包括３端ｐｏｌｙ（Ａ）尾〕,两者间仅有１３个位点不同,同源性达９９．８％,在进化树上位于同     

食块茎水鸟及水位对沙湖沉水植物冬芽分布的影响

分别于2012—2013、2013—2014年度越冬期候鸟越冬前(10月份)与越冬后(4月份)采用样方法调查沙湖沉水植物冬芽的种类、密度及生物量,分析不同水位条件的2个年度鄱阳湖碟形子湖沉水植物冬芽的分布及其对食块茎水鸟食物贡献的差异性,探讨越冬水鸟取食与水位变化对沉水植物冬芽分布的影响。结果表明:刺苦草(Vallisneria spinulosa)和罗氏轮叶黑藻(Hydrilla verticillata var.rosburghii)2种沉水植物的冬芽同域分布。2013年10月2种植物冬芽的密度与生物量均显著低于2012年同期,主要原因是鄱阳湖水位年际间变化剧烈,并对水质有显著影响:与2012年相比,2013年丰水期(4—9月)沙湖与主湖区连通的时间和日平均水深显著减小,但水体浊度显著增加,不利于沉水植物生长发育。2012—2013年度越冬水鸟迁出后2种冬芽的密度和生物量均明显下降,而2013—2014年度越冬期水鸟迁出后与迁入前相比两种植物冬芽的密度和生物量均无显著变化,很可能与食块茎水鸟的取食活动和高水位对食物可利用性的负面影响有密切关系。湖泊剧烈的水位变化导致越冬水鸟的食源具有年际波动的特征,而食块茎水鸟对鄱阳湖子湖的食物利用率受越冬季冬芽丰富度和食物可及性(accessibility)的共同影响。研究结果对鄱阳湖乃至长江中下游流域沉水植被恢复、越冬水鸟保护以及生态系统功能评估具有指导意义。     

三种不同方法固定的石蜡切片中RNA的分析

研究在 10 %中性福尔马林、丙酮、甲醇 氯仿 冰醋酸 3种方法固定的石蜡切片中提取RNA的质量和数量 .取 2 5 0g体重的Wistar大鼠的肾脏 ,分别采用 10 %中性福尔马林、丙酮、甲醇 氯仿 冰醋酸 3种方法固定 ,石蜡包埋 ,H E染色 ;采用RNA裂解液、TRIZOL试剂 2种方法提取切片RNA ,逆转录为cDNA ,采用普通PCR和SYBRGREEN 1定量PCR分析RNA质量和数量 .结果表明 ,3种固定方法都可保持组织良好的结构和形态 ;采用 2种提取方法 ,均可经RT PCR扩增出 180bp大鼠磷酸甘油醛脱氢酶 (G3PDH)、5 6 5bpβ肌动蛋白 (β actin)、10 0bp纤溶酶系活化剂抑制物 1(PAI 1) ;但采用RNA裂解液时 ,比TRIZOL试剂可提取更多的RNA .     

老年冠心病患者服用抗血小板药物的依从性分析及护理对策

目的:分析老年冠心痛患者服用抗血小板药物的依从性,寻求护理干预的有效途径.方法:自行设计服用抗血小板药物依从性调查表,通过调查与健康教育相结合的方式,对128例年龄在68～95岁的老年冠心病患者服药依从性问题进行调查分析.结果:通过临床医师知道抗血小板药物作用的占100%;知道终身服用抗血小板药物意义的占35%;服用抗血小板药物遇到问题而自行停药的占0%;健康教育后能坚持终身服用抗血小板药物的占95%.结论:相对于老年冠心痛患者,有效的健康教育能极大地提高患者服药依从性.临床医护人员对患者进行健康教育的同时,对家属的教育也很重要.通过健康教育干预,使其掌握药物的基本知识,告知获益大于风险,启动家庭支持系统,可显著提高老年冠心病患者服用抗血小板药物依从性.     

Oxygen‐Deficient Blue TiO2 for Ultrastable and Fast Lithium Storage

Developing a titanium dioxide (TiO₂)‐based anode with superior high‐rate capability and long‐term cycling stability is important for efficient energy storage. Herein, a simple one‐step approach for fabricating blue TiO₂ nanoparticles with oxygen vacancies is reported. Oxygen vacancies can enlarge lattice spaces, lower charge transfer resistance, and provide more active sites in TiO₂ lattices. As a result, this blue TiO₂ electrode exhibits a highly reversible capacity of 50 mAh g^?1 at 100 C (16 800 mA g^?1) even after 10 000 cycles, which is attributable to the combination of surface capacitive process and remarkable diffusion‐controlled insertion revealed by the kinetic analysis. The strategy of employing oxygen‐deficient nanoparticles may be extended to the design of other robust semiconductor materials as electrodes for energy storage.     

20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer

Castration-resistant progression of prostate cancer after androgen deprivation therapies remains the most critical challenge in the clinical management of prostate cancer. Resurgent androgen receptor (AR) activity is an established driver of castration-resistant progression, and upregulation of the full-length AR (AR-FL) and constitutively-active AR splice variants (AR-Vs) has been implicated to contribute to the resurgent AR activity. We reported previously that ginsenoside 20(S)-protopanaxadiol-aglycone (PPD) can reduce the abundance of both AR-FL and AR-Vs. In the present study, we further showed that the effect of PPD on AR expression and target genes was independent of androgen. PPD treatment resulted in a suppression of ligand-independent AR transactivation. Moreover, PPD delayed castration-resistant regrowth of LNCaP xenograft tumors after androgen deprivation and inhibited the growth of castration-resistant 22Rv1 xenograft tumors with endogenous expression of AR-FL and AR-Vs. This was accompanied by a decline in serum prostate-specific antigen levels as well as a decrease in AR levels and mitoses in the tumors. Notably, the 22Rv1 xenograft tumors were resistant to growth inhibition by the next-generation anti-androgen enzalutamide. The present study represents the first to show the preclinical efficacy of PPD in inhibiting castration-resistant progression and growth of prostate cancer. The findings provide a rationale for further developing PPD or its analogues for prostate cancer therapy.